Show simple item record

 
dc.contributorDepartament de Salut
dc.contributor.authorPrograma d'Harmonització Farmacoterapèutica
dc.date.accessioned2020-05-04T11:59:37Z
dc.date.available2020-05-04T11:59:37Z
dc.date.issued2020-05-01
dc.identifier.citationPrograma d’Harmonització Farmacoterapèutica. Coronavirus SARS-CoV-2: nota informativa sobre el maneig de la teràpia hormonal de la menopausa i el tractament anticonceptiu en la COVID-19 [fullet]. Barcelona: Servei Català de la Salut; 2020.
dc.identifier.urihttp://hdl.handle.net/11351/4895
dc.descriptionCoronavirus SARS-CoV-2; COVID-19; 2019-nCoV; Menopause; Hormone therapy; Contraceptive treatment
dc.description.abstractThe aim of this paper is to describe the considerations to be considered in women treated with menopausal hormone therapy (THM) or combined hormonal contraception (AHC) in the context of a coronavirus infection or suspected infection. SARS-CoV-2 for the risk of VTE associated with these treatments.
dc.language.isocat
dc.publisherServei Català de la Salut
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectCOVID-19 (Malaltia)
dc.subjectMenopausa- Hormonoteràpia
dc.subjectContraceptius
dc.subject.meshMenopause
dc.subject.meshHormonal Contraception
dc.subject.mesh/drug therapy
dc.subject.meshCoronavirus Infections
dc.titleCoronavirus SARS-CoV-2: nota informativa sobre el maneig de la teràpia hormonal de la menopausa i el tractament anticonceptiu en la COVID-19 [fullet]
dc.typeinfo:eu-repo/semantics/other
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsmenopausia
dc.subject.decsanticoncepción
dc.subject.decs/tratamiento farmacológico
dc.type.subtypeFullet
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record